Abstract
A growing body of research suggests the involvement of immune system factors in central nervous system development and in pathophysiology related to schizophrenia. 1, 2 We therefore investigated the Tumor Necrosis Factor Receptor-II (TNF-RII), a TNFα receptor expressed in fetal brain, as a candidate disease gene for schizophrenia. We also investigated the relationship between TNF-RII and adult brain morphology. The study sample consisted of 140 probands diagnosed with schizophrenia or schizophreniform disorder, 197 parents of the probands (a subset of which formed 62 proband-parent trios), and 46 psychiatrically normal control subjects. A bi-allelic TNF-RII polymorphism was examined for evidence of association, with none being found between this polymorphism and schizophrenia. Subjects with schizophrenia homozygous for allele 1, however, had larger ventricles and smaller frontal lobes than subjects with at least one copy of allele 2. On follow-up testing, they also had an earlier, less variable age of onset for their illness. We found no support, therefore, for TNF-RII as a disease susceptibility gene for schizophrenia. The gene may, however, modify phenotypic aspects of the disease such as brain morphology and age of onset of illness.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Muller N, Ackenheil M . Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders Prog Neuropsychopharmacol Biol Psychiatry 1998; 22: 1–33
Zhao B, Schwartz JP . Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives J Neurosci Res 1998; 52: 7–16
Merrill JE . Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological Dev Neurosci 1992; 14: 1–10
Munoz-Fernandez MA, Fresno M . The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system Prog Neurobiol 1998; 56: 307–340
De Simoni MG, Imeri L . Cytokine-neurotransmitter interactions in the brain Biol Signals Recept 1998; 7: 33–44
Monteleone P, Fabrazzo M, Tortorella A, Maj M . Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment Psychiatry Res 1997; 71: 11–17
Wilke I, Arolt V, Rothermundt M, Weitzsch C, Hornberg M, Kirchner H . Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients Eur Arch Psychiatry Clin Neurosci 1996; 246: 279–284
Naudin J, Capo C, Giusano B, Mege JL, Azorin JM . A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia? Schizophr Res 1997; 26: 227–233
Rothwell NJ, Luheshi G, Toulmond S . Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology Pharmacol Ther 1996; 69: 85–95
Andreasen NC, Flashman L, Flaum M, Arndt S, Swayze VN, O'Leary DS et al. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging Jama 1994; 272: 1763–1769
Pearlson GD, Marsh L . Structural brain imaging in schizophrenia: a selective review Biol Psychiatry 1999; 46: 627–649
Bilder RM, Wu H, Bogerts B, Degreef G, Ashtari M, Alvir JM et al. Absence of regional hemispheric volume asymmetries in first-episode schizophrenia Am J Psychiatry 1994; 151: 1437–1447
Nopoulos P, Torres I, Flaum M, Andreasen NC, Ehrhardt JC, Yuh WT . Brain morphology in first-episode schizophrenia Am J Psychiatry 1995; 152: 1721–1723
Campbell IL . Transgenic mice and cytokine actions in the brain: bridging the gap between structural and functional neuropathology Brain Res Brain Res Rev 1998; 26: 327–336
Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors Nature Med 1996; 2: 788–794
Vargas F, Tolosa E, Sospedra M, Catalfamo M, Lucas-Martin A, Obiols G et al. Characterization of neural cell adhesion molecule (NCAM) expression in thyroid follicular cells: induction by cytokines and over-expression in autoimmune glands Clin Exp Immunol 1994; 98: 478–488
Rothwell NJ, Luheshi GN . Brain TNF: damage limitation or damaged reputation? Nature Med 1996; 2: 746–747
Cheng B, Christakos S, Mattson MP . Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis Neuron 1994; 12: 139–153
Rink L, Kirchner H . Recent progress in the tumor necrosis factor-alpha field Int Arch Allergy Immunol 1996; 111: 199–209
Jarskog LF, Xiao H, Wilkie MB, Lauder JM, Gilmore JH . Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro Int J Dev Neurosci 1997; 15: 711–716
Vandanabeele P, DePercq W, Beyaert R, Fiers W . Two tumour necrosis factor receptors: structure and functions Trends Biochem Sci 1995; 5: 392–399
Ando T, Dunn AJ . Mouse tumor necrosis factor-alpha increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice Neuroimmunomodulation 1999; 6: 319–329
Hayley S, Brebner K, Lacosta S, Merali Z, Anisman H . Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations J Neurosci 1999; 19: 5654–5665
Dunn AJ, Wang J, Ando T . Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress Adv Exp Med Biol 1999; 461: 117–127
Silverman JM, Smith CJ, Guo SL, Mohs RC, Siever LJ, Davis KL . Lateral ventricular enlargement in schizophrenic probands and their siblings with schizophrenia-related disorders Biol Psychiatry 1998; 43: 97–106
Cannon TD, van Erp TGM, Huttunen M, Lonnqvist J, Salonen O, Valanne L et al. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenia patients, their siblings, and controls Arch Gen Psychiatry 1998; 55: 1084–1091
Shihabuddin L, Silverman JM, Buchsbaum MS, Seiver LJ, Luu C, Germans MK et al. Ventricular enlargement associated with linkage marker for schizophrenia-related disorders in one pedigree Mol Psychiatry 1996; 1: 215–222
Wassink TH, Nelson JJ, Crowe RR, Andreasen NC . Heritability of BDNF alleles and their effect on brain morphology in schizophrenia Am J Med Genet 1999; 88: 724–728
Andreasen NC, Flaum M, Arndt S . The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology Arch Gen Psychiatry 1992; 49: 615–623
Rau H, Donner H, Usadel KH, Badenhoop K . Polymorphisms of tumor necrosis factor receptor 2 are not associated with insulin-dependent diabetes mellitus or Grave's disease Tissue Antigens 1997; 49: 535–536
Spielman RS, McGinnis RE, Ewens WJ . Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM) Am J Hum Genet 1993; 52: 506–516
Andreasen NC, Cohen G, Harris G, Cizadlo T, Parkkinen J, Rezai K et al. Image processing for the study of brain structure and function: problems and programs J Neuropsychiatry Clin Neurosci 1992; 4: 125–133
Andreasen NC, Cizadlo T, Harris G, Swayze Vd, O'Leary DS, Cohen G et al. Voxel processing techniques for the antemortem study of neuroanatomy and neuropathology using magnetic resonance imaging J Neuropsychiatry Clin Neurosci 1993; 5: 121–130
Magnotta VA, Heckel D, Andreasen NC, Cizadlo T, Corson PW, Ehrhardt JC et al. Measurement of brain structures with artificial neural networks: two- and three-dimensional applications Radiology 1999; 211: 781–790
Woods RP, Cherry SR, Mazziotta JC . Rapid automated algorithm for aligning and reslicing PET images J Comput Assist Tomogr 1992; 16: 620–633
Harris G, Andreasen NC, Cizadlo T, Bailey JM, Bockholt J, Magnotta V et al. Improving tissue classification in magnetic resonance imaging: a three-dimensional multispectral discriminant analysis method with automated training class selection J Comput Assist Tomogr 1999; 23: 144–154
Talairach J, Tournoux P . Co-planar Stereotaxic Atlas of the Human Brain Theime: New York 1988
Andreasen NC, Rajarethinam R, Cizadlo T, Arndt S, Swayze VWn, Flashman LA et al. Automatic atlas-based volume estimation of human brain regions from MR images J Comput Assist Tomogr 1996; 20: 98–106
Acknowledgements
Supported in part by NIMH grants MH43212 and MH00735 (RRC), and MH-31593 and MH-40856 (NCA); MHCRC grant MH-43271; the Nellie Ball Trust Research Fund (Iowa State Bank and Trust Company, Trustee); and a NARSAD Young Investigator Award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wassink, T., Crowe, R. & Andreasen, N. Tumor necrosis factor receptor-II: heritability and effect on brain morphology in schizophrenia. Mol Psychiatry 5, 678–682 (2000). https://doi.org/10.1038/sj.mp.4000807
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000807
Keywords
This article is cited by
-
Association of the Met-196-Arg Variation of Human Tumor Necrosis Factor Receptor 2 (TNFR2) with Paranoid Schizophrenia
Journal of Molecular Neuroscience (2011)
-
TNFRSF11B computational development network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients
Journal of Inflammation (2010)
-
Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow
Molecular Psychiatry (2005)
-
Interaction of tumor necrosis alpha – G308A and epidermal growth factor gene polymorphisms in early–onset schizophrenia
European Archives of Psychiatry and Clinical Neuroscience (2005)
-
Prenatal Infection and Risk for Schizophrenia: IL-1β, IL-6, and TNFα Inhibit Cortical Neuron Dendrite Development
Neuropsychopharmacology (2004)